Amylyx expects completion of recruitment for the LUCIDITY trial in 2025, with topline data in first half of 2026 Pivotal Phase 3 LUCIDITY trial evaluating avexitide, a GLP-1 receptor antagonist with FDA Breakthrough Therapy Designation and Orphan Drug Designation; FDA-agreed-upon primary outcome of reduction in hypoglycemic events Avexitide has been previously evaluated in five post-bariatric … [Read more…]

Innovation engine drives meaningful clinical, regulatory, and financial milestones, including positive Phase 2b results for wholly-owned deupirfenidone (LYT-100) in IPF, compelling Phase 1b data for wholly-owned LYT-200 in AML and solid tumors, FDA approval of PureTech-invented Cobenfy™1 for schizophrenia, and rapid growth of Founded Entity2, Seaport Therapeutics, which raised over $325 million Capital-efficient operations support … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–The California Center for Reproductive Health (CCRH), the highest-rated fertility clinic on Yelp in Los Angeles, has been named one of America’s Best Fertility Clinics by Newsweek for the third consecutive year. The award recognizes CCRH’s outstanding success rates, inclusive care, and long-standing reputation as a trusted leader in reproductive medicine. This honor … [Read more…]

The inaugural global engagement survey provides certification for all countries in which the company operates. MANILA, Philippines–(BUSINESS WIRE)–#ClinicalTalent—Shearwater Health, a leader in clinician-led clinical solutions for healthcare partners, proudly announces its certification as a Great Place to Work® across all of its markets: the United States, Philippines, and India. This prestigious recognition is based on … [Read more…]

— XENITH-UC, a Phase 2b study of XmAb942 in participants with ulcerative colitis, to begin in the second half of 2025 — — Single and multiple doses of XmAb942 are well tolerated and safety profile is consistent with the anti-TL1A drug class — — XmAb942 half-life supports a 12-week maintenance dosing interval in XENITH-UC — … [Read more…]

OMAHA, Neb.–(BUSINESS WIRE)–Titan Nurse Staffing, LLC (“TNS”), a Delaware limited liability company, is pleased to announce its upcoming merger with Titan Medical Group, LLC (“Titan Medical”), also a Delaware limited liability company. Both TNS and Titan Medical are wholly owned subsidiaries of Titan Medical Holdings, Inc., a leading provider of healthcare staffing solutions nationwide. Under … [Read more…]

Leaders from across Southern New Jersey join the Foundation Board to amplify vital hospital programs and aid in the expansion of Inspira’s cardiac care MULLICA HILL, N.J.–(BUSINESS WIRE)–Inspira Health is proud to announce new leadership for its Foundation Board of Trustees. The board is dedicated to promoting philanthropy that supports critical Inspira Health programs that … [Read more…]

Promega MSI technology is now available in a diagnostic test in China National Medical Products Administration (NMPA) awarded a medical device registration certificate to Promega ProDx MSI Detection Kit ProDx MSI Detection Kit will be used to screen colorectal cancer patients to identify those who may benefit from additional genetic testing to diagnose Lynch syndrome … [Read more…]

BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that its board of directors (the “Board”) issued a public letter to shareholders in response to hostile actions and false claims by Vivo Capital and certain other parties (the “Vivo group”) against the legitimate and … [Read more…]

Effective July 1, 2025, he will succeed Oliver Rittgen who has decided to pursue a career opportunity outside of Bayer after 25 years with the company Guru Ramamurthy has extensive expertise in finance and is currently serving as CFO of Bayer US MONHEIM, Germany–(BUSINESS WIRE)–Bayer announced today that Guru Ramamurthy will become the new Chief … [Read more…]